mhurhangee/ep-ind-claims huggingface dataset:
A pick and place gripper device (100, 200) for picking up and re-positioning a deformable food item carried by a support surface, comprising: • a pair of jaws (101, 102, 201, 202) configured to move by a first moving means from an open position to a closed position, and vice versa, wherein the pick and place gripper device further comprises: • a frame structure (103, 203) arranged between the jaws (101, 102, 201, 202) comprising an outer frame and a top frame, wherein the jaws are designed such that in the closed position the jaws define a cavity for shaping and carrying the deformable food item where the cavity comprises a side wall and a bottom, wherein after picking up the deformable food item by the jaws, the frame structure and/or the pair of jaws are configured to move relative towards each other, such that the outer frame supplies a pressure onto the deformable food item causing the deformable food item to be at least partly compressed into the frame structure where it is retained in a compact pre-shaped form, wherein said pick and place gripper device (100, 200) is configured for moving the jaws from the closed position to the open position while the frame structure preserves the deformable food item in the compact pre-shaped form when releasing the deformable food item, characterised in that said pick and place gripper device (100, 200) is configured for subsequently moving the frame structure down to a stop position causing a releasing of the deformable food item in the compact pre-shaped form at the re-positioning position, where the outer frame essentially follows the shape of the side wall of the cavity, and wherein the geometry of the outer frame corresponds to the inner geometry of the jaws (201, 202) when being in closed position such that the outer frame slides/touches the side walls of the jaws. • a pair of jaws (101, 102, 201, 202) configured to move by a first moving means from an open position to a closed position, and vice versa, • a frame structure (103, 203) arranged between the jaws (101, 102, 201, 202) comprising an outer frame and a top frame,
A monoclonal antibody molecule recognizing a conformational epitope formed by Phe at amino acid position 4 of trimeric or tetrameric human Aβ, as determined by pepscan ELISA comprising the steps of precoating with 100 ng Aβ 4-19 and Aβ 5-20, blocking, incubating with 7 μg/ml of said antibody molecule, and detecting said antibody molecule with a labeled secondary antibody; wherein said antibody molecule does not bind human monomeric Aβ 1-42 or human Aβ 1-42 dimers, as determined by native Western-blotting comprising the steps of applying 7 μg Aβ 1-42 on a 18% SDS-free polyacrylamide gel, transferring on a 0.45 μm nitrocellulose membrane, blocking, incubating with said antibody molecule in a concentration of not more than 10 μg/ml for 2 h at room temperature, and detecting said antibody molecule with a labeled secondary antibody; and wherein said antibody molecule comprises (a) a variable region comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 7, and comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 8 (NT4X-83); or (b) a variable region comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 15, and comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 16 (NT4X-167). (a) a variable region comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 7, and comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 8 (NT4X-83); or (b) a variable region comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 15, and comprising an amino acid sequence which is at least 80% identical to the amino acid sequence as shown in SEQ ID NO: 16 (NT4X-167).
A positioning apparatus for a solar panel cleaning robot, the solar panel cleaning robot comprising a vehicle body configured to move or stop on at least one solar panel, each solar panel being rectangular in shape, four recognizable frame edges being disposed on edges of each solar panel, lines of latitude and longitude perpendicular to one another being disposed on each solar panel to form a coordinate system, characterized in that the positioning apparatus comprises: at least one image capturing unit configured to acquire peripheral images including images of the vehicle body in real-time; a body edge recognizing unit connected to the at least one image capturing unit and configured to recognize body edges of the vehicle body according to the images and a moving direction of the vehicle body; a latitude-and-longitude line recognizing unit connected to the at least one image capturing unit and configured to recognize the numbers of latitude lines and longitude lines existing between the vehicle body and the frame edges according to the images and positions of the frame edges; and a vehicle-body position calculating unit connected to the latitude-and-longitude line recognizing unit and configured to calculate a coordinate scope of the vehicle body on the at least one solar panel according to the numbers of latitude lines and longitude lines between the vehicle body and the frame edges. at least one image capturing unit configured to acquire peripheral images including images of the vehicle body in real-time; a body edge recognizing unit connected to the at least one image capturing unit and configured to recognize body edges of the vehicle body according to the images and a moving direction of the vehicle body; a latitude-and-longitude line recognizing unit connected to the at least one image capturing unit and configured to recognize the numbers of latitude lines and longitude lines existing between the vehicle body and the frame edges according to the images and positions of the frame edges; and a vehicle-body position calculating unit connected to the latitude-and-longitude line recognizing unit and configured to calculate a coordinate scope of the vehicle body on the at least one solar panel according to the numbers of latitude lines and longitude lines between the vehicle body and the frame edges.
Aircraft wing, having a leading edge and a trailing edge, a lower surface and an upper surface and comprising at least one first, fixed aerodynamic component and a second aerodynamic component, said first, fixed aerodynamic component comprising a box section covered at least partly by a plate (6A, 6B) and said second aerodynamic component comprising a peripheral surface forming part both of the upper surface and of the lower surface of the wing, said plate (6A, 6B) comprising at least one extreme part (7A, 7B), said peripheral surface being provided with at least one end (15A, 15B), said wing comprising at least one holding element (8A, 8B) provided with a shoulder (9A, 9B), said wing being characterized in that said shoulder (9A, 9B) forms, with said at least one extreme part (7A, 7B) of said plate (6A, 6B), a groove (12A, 12B) in which said at least one end (15A, 15B) of said peripheral surface is able to be housed, such that said peripheral surface and said plate (6A, 6B) form a junction having an ascending profile, namely a profile whose height increases going from the leading edge to the trailing edge along a cord line of the wing.
A device for filtering intake air of an internal combustion engine, comprising at least one filtering element having an inlet for air being treated, a first clean air outlet towards the engine and a second air outlet towards the outside, a ventilation means impelling the air from said second air outlet, the ventilation means including a fan wheel driven by a turbine which is set in motion by a gas flow taken from the engine, characterized by the fact that the turbine and the fan wheel are arranged concentrically with respect to one another, the fan wheel and the turbine form a rotor mounted in a casing in which are formed a first, central, channel for ventilation air and a second channel, having the shape of at least one ring sector, for supplying the turbine, the second channel being concentric to the first channel wth two wall elements (35, 36) and being with inlet and an axial inlet.
A mixer (10, 10') for mixing multi-component materials (102a, 102b), the mixer (10, 10') comprising - a mixing element arranged at a longitudinal axis of the mixer (10, 10') for mixing multi-component materials (102a, 102b); - an inlet section arranged at the longitudinal axis; wherein said inlet section comprises - a first channel for conducting a first component from an inlet side to an outlet side, wherein said first channel splits up into a set of sub-channels within the inlet section, the set of sub-channels opening into a set of first outlets arranged at the outlet side and the first outlets being configured to direct a flow of a first component of the multi-component material to the mixing element arranged at the outlet side, characterized in that said first channel further splits up into a set of sub-passages prior to splitting up into said set of sub-channels within the inlet section; and in that the inlet section further comprises - an outlet region; and - a second channel for conducting a second component from the inlet side to the outlet side, wherein said second channel has only one second outlet at the outlet region with the second outlet surrounding the first outlets. - a mixing element arranged at a longitudinal axis of the mixer (10, 10') for mixing multi-component materials (102a, 102b); - an inlet section arranged at the longitudinal axis; - a first channel for conducting a first component from an inlet side to an outlet side, wherein said first channel splits up into a set of sub-channels within the inlet section, the set of sub-channels opening into a set of first outlets arranged at the outlet side and the first outlets being configured to direct a flow of a first component of the multi-component material to the mixing element arranged at the outlet side, characterized in that said first channel further splits up into a set of sub-passages prior to splitting up into said set of sub-channels within the inlet section; - an outlet region; and - a second channel for conducting a second component from the inlet side to the outlet side, wherein said second channel has only one second outlet at the outlet region with the second outlet surrounding the first outlets.
An air conditioner pipeline, comprising a pipe body, wherein a flow channel for a refrigerant to flow is formed by an inner side of a pipe wall of the pipe body; the pipe wall of the pipe body is provided with at least two conductive parts and insulating parts; the conductive parts are configured to transmit power to the air conditioner, and the insulating parts are configured to realize insulation between the conductive parts; the conductive parts are made of metal conductive materials, and the conductive parts are configured as power transmission lines, and wherein the pipe wall of the pipe body directly forms the conductive parts as power transmission lines.
An intraoral device, comprising: a flexible body, comprising: an upper front flap including evacuation holes and an upper edge; an upper rear flap forming an upper pocket with the upper front flap and including internal evacuation channels (418, 419) and an upper edge separated from the upper edge of the upper front flap to form an upper pocket opening, the internal evacuation channels (418, 419) terminating in grooves along the upper edge of the upper rear flap; a lower front flap including evacuation holes and a lower edge; a lower rear flap forming a lower pocket with the lower front flap and including internal evacuation channels (418, 419) and a lower edge separated from the lower edge of the lower front flap to form a lower pocket opening, the internal evacuation channels (418, 419) terminating in grooves along the lower edge of the lower rear flap, wherein in a non-vacuum state the upper pocket opening and lower pocket opening are open and in a vacuum state the upper pocket opening and lower pocket opening are substantially sealed closed so that aspiration of fluids from the patient's mouth occurs through the evacuation holes in the front flaps (310, 330) and grooves, which become fluid inlets for drawing fluids through the internal evacuation channels (418, 419) of the rear flaps (320, 340). an upper front flap including evacuation holes and an upper edge; an upper rear flap forming an upper pocket with the upper front flap and including internal evacuation channels (418, 419) and an upper edge separated from the upper edge of the upper front flap to form an upper pocket opening, the internal evacuation channels (418, 419) terminating in grooves along the upper edge of the upper rear flap; a lower front flap including evacuation holes and a lower edge; a lower rear flap forming a lower pocket with the lower front flap and including internal evacuation channels (418, 419) and a lower edge separated from the lower edge of the lower front flap to form a lower pocket opening, the internal evacuation channels (418, 419) terminating in grooves along the lower edge of the lower rear flap, wherein in a non-vacuum state the upper pocket opening and lower pocket opening are open and in a vacuum state the upper pocket opening and lower pocket opening are substantially sealed closed so that aspiration of fluids from the patient's mouth occurs through the evacuation holes in the front flaps (310, 330) and grooves, which become fluid inlets for drawing fluids through the internal evacuation channels (418, 419) of the rear flaps (320, 340).
An aerogel composite prepared by drying a wet gel generated from a sol, wherein the sol comprises silica particles, at least one selected from the group consisting of a silicon compound having a hydrolyzable alkoxy group in the molecule and a hydrolysis product of the silicon compound, and at least one selected from the group consisting of a polysiloxane compound having a reactive group in the molecule and a hydrolysis product of the polysiloxane compound, the content of the silica particles is 1 to 20 parts by mass with respect to the total amount of the sol as 100 parts by mass, the content of the silicon compounds is 5 to 50 parts by mass with respect to the total amount of the sol as 100 parts by mass, the total sum of the contents of silicon compounds and polysiloxane compounds is 5 to 50 parts by mass with respect to the total amount of the sol as 100 parts by mass, and the average primary particle diameter of the silica particles is 20 to 100 nm. the sol comprises silica particles, at least one selected from the group consisting of a silicon compound having a hydrolyzable alkoxy group in the molecule and a hydrolysis product of the silicon compound, and at least one selected from the group consisting of a polysiloxane compound having a reactive group in the molecule and a hydrolysis product of the polysiloxane compound, the content of the silica particles is 1 to 20 parts by mass with respect to the total amount of the sol as 100 parts by mass, the content of the silicon compounds is 5 to 50 parts by mass with respect to the total amount of the sol as 100 parts by mass, the total sum of the contents of silicon compounds and polysiloxane compounds is 5 to 50 parts by mass with respect to the total amount of the sol as 100 parts by mass, and the average primary particle diameter of the silica particles is 20 to 100 nm.
A battery comprising: a plurality of battery cells (106, 206) arranged in a column, and comprising an alternating series of first cells and second cells, each of the cells having a top and bottom side and a left and right side, each cell having a maximum expected peak temperature caused by thermal runaway; and a first thermal bus having a substantially planar portion to the left side of each first cell and a first plurality of flanges extending perpendicularly from the planar portion, each flange in the first plurality of flanges contacting one of the first cells; and characterised in that the battery comprises: a second thermal bus having a substantially planar portion to the right side of each second cell and a second plurality of flanges extending perpendicularly from the planar portion without contacting the first thermal bus, each flange in the second plurality of flanges contacting one of the second cells; and a single insulator (110, 210) in contact with each cell and preventing direct physical contact between each first cell and an adjacent second cell. a plurality of battery cells (106, 206) arranged in a column, and comprising an alternating series of first cells and second cells, each of the cells having a top and bottom side and a left and right side, each cell having a maximum expected peak temperature caused by thermal runaway; and a first thermal bus having a substantially planar portion to the left side of each first cell and a first plurality of flanges extending perpendicularly from the planar portion, each flange in the first plurality of flanges contacting one of the first cells; and a second thermal bus having a substantially planar portion to the right side of each second cell and a second plurality of flanges extending perpendicularly from the planar portion without contacting the first thermal bus, each flange in the second plurality of flanges contacting one of the second cells; and a single insulator (110, 210) in contact with each cell and preventing direct physical contact between each first cell and an adjacent second cell.
An inkjet ink comprising: a polyamide resin; at least one kind of tackifier selected from the group consisting of a terpene phenol resin and a rosin ester whose hydroxyl value is 10 mgKOH/g or more and is 45 mgKOH/g or less; a solvent dye; and an alcohol having 1 to 3 carbon atoms. a polyamide resin; at least one kind of tackifier selected from the group consisting of a terpene phenol resin and a rosin ester whose hydroxyl value is 10 mgKOH/g or more and is 45 mgKOH/g or less; a solvent dye; and an alcohol having 1 to 3 carbon atoms.
Ultrasonic transducer comprising: - at least one piezoelectric wafer having two parallel planar main faces: a front face and a posterior face, - at least one posterior plate having two parallel planar main faces: an anterior face and a rear face, the anterior face of said posterior plate extending facing, and in contact with, the posterior face of the piezoelectric wafer, - the posterior plate has a thickness between three and seven times the thickness of the piezoelectric wafer, characterised in that: - the posterior plate has an acoustic impedance between 10 MPa.s.m -1 and 35 MPa.s.m -1. - at least one piezoelectric wafer having two parallel planar main faces: a front face and a posterior face, - at least one posterior plate having two parallel planar main faces: an anterior face and a rear face, the anterior face of said posterior plate extending facing, and in contact with, the posterior face of the piezoelectric wafer, - the posterior plate has a thickness between three and seven times the thickness of the piezoelectric wafer, - the posterior plate has an acoustic impedance between 10 MPa.s.m -1 and 35 MPa.s.m -1.
A crystal form of a compound of formula I, wherein the crystal form is selected from the group consisting of crystal form A, crystal form B and crystal form C the X-ray powder diffraction pattern of the crystal form A includes 3 or more 2θ values selected from the group consisting of 3.72±0.2°, 7.47±0.2°, 11.44±0.2°, 12.28±0.2°, 21.59±0.2°; the X-ray powder diffraction pattern of the crystal form B includes 3 or more 2θ values selected from the group consisting of: 5.37±0.2°, 12.01±0.2°, 14.93±0.2°, 16.04±0.2°, 20.09±0.2°; the X-ray powder diffraction pattern of the crystal form C includes 3 or more 2θ values selected from the group consisting of: 6.63±0.2°, 11.16±0.2°, 17.06±0.2°, 19.46±0.2°, 20.84±0.2°, 25.74±0.2°; the test parameters of XRD are as follows: instrument model: Bruker D8advance; target: Cu-K α (40 kV, 40 mA); sample to detector distance: 30 cm; scanning range: 3°∼ 40°(2 theta value); scanning step: 0.1 s. the X-ray powder diffraction pattern of the crystal form A includes 3 or more 2θ values selected from the group consisting of 3.72±0.2°, 7.47±0.2°, 11.44±0.2°, 12.28±0.2°, 21.59±0.2°; the X-ray powder diffraction pattern of the crystal form B includes 3 or more 2θ values selected from the group consisting of: 5.37±0.2°, 12.01±0.2°, 14.93±0.2°, 16.04±0.2°, 20.09±0.2°; the X-ray powder diffraction pattern of the crystal form C includes 3 or more 2θ values selected from the group consisting of: 6.63±0.2°, 11.16±0.2°, 17.06±0.2°, 19.46±0.2°, 20.84±0.2°, 25.74±0.2°; the test parameters of XRD are as follows: instrument model: Bruker D8advance; target: Cu-K α (40 kV, 40 mA); sample to detector distance: 30 cm; scanning range: 3°∼ 40°(2 theta value); scanning step: 0.1 s.
An inhibitor of apoptosis protein antagonist for use in a method of treating cancer in a human subject, the method comprising: (i) administering the IAP antagonist during an induction period, wherein the duration of the induction period is selected from the range of 1 to 48 days before first administration of an anti-PD-1 molecule; followed by (ii) administering an anti-PD-1 molecule after the end of the induction period; wherein: the anti-PD-1 molecule is Nivolumab, Pembrolizumab, Atezolizumab, Durvalumab, Avelumab, PDR001, IBI-308, Cemiplimab, Camrelizumab, BGB-A317, BCD-100, JS-001, JNJ-3283, MEDI0680, AGEN-2034, TSR-042, Sym-021, PF-06801591, MGD-013, MGA-012, LZM-009, GLS-010, Genolimzumab, B! 754091, AK-104, CX-072, WBP3155, SHR-1316, PD-L1 Inhibitor millamolecule, BMS-936559, M-7824, LY-3300054, KN-035, FAZ-053, CK-301, or CA-170; and the IAP antagonist administered during the induction period is Debio 1143, GDC-917/CUDC-427, LCL161, GDC-0152, TL-32711/Birinapant, HGS-1029/AEG-40826, B! 891065, ASTX-660 or APG-1387, preferably, the IAP antagonist is Debio 1143, LCL161 or Birinapant. (i) administering the IAP antagonist during an induction period, wherein the duration of the induction period is selected from the range of 1 to 48 days before first administration of an anti-PD-1 molecule; followed by (ii) administering an anti-PD-1 molecule after the end of the induction period; the anti-PD-1 molecule is Nivolumab, Pembrolizumab, Atezolizumab, Durvalumab, Avelumab, PDR001, IBI-308, Cemiplimab, Camrelizumab, BGB-A317, BCD-100, JS-001, JNJ-3283, MEDI0680, AGEN-2034, TSR-042, Sym-021, PF-06801591, MGD-013, MGA-012, LZM-009, GLS-010, Genolimzumab, B! 754091, AK-104, CX-072, WBP3155, SHR-1316, PD-L1 Inhibitor millamolecule, BMS-936559, M-7824, LY-3300054, KN-035, FAZ-053, CK-301, or CA-170; and the IAP antagonist administered during the induction period is Debio 1143, GDC-917/CUDC-427, LCL161, GDC-0152, TL-32711/Birinapant, HGS-1029/AEG-40826, B! 891065, ASTX-660 or APG-1387, preferably, the IAP antagonist is Debio 1143, LCL161 or Birinapant.